-
Product Insights
Emphysema – Drugs In Development, 2023
Global Markets Direct’s, ‘Emphysema - Drugs In Development, 2023’, provides an overview of the Emphysema pipeline landscape. The report provides comprehensive information on the therapeutics under development for Emphysema, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...
-
Product Insights
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Chronic Obstructive Pulmonary Disease (COPD) Clinical Trial Report Overview The total number of chronic obstructive pulmonary disease (COPD) clinical trials conducted as of December 2023 was 3,584. The COPD clinical trial report includes information about the sponsor type and the prominent sponsors associated with the COPD clinical trials. The report provides a comprehensive understanding of the COPD clinical trial scenario across regions and countries (G7 & E7), covering details on the various phases, trial status, and end points status. The...
-
Sector Analysis
Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Market Report Overview COPD is a progressive lung disease characterized by an abnormal inflammatory response and airflow obstruction that is not fully reversible. Chronic airflow limitation is caused both by small airway diseases, such as obstructive bronchiolitis, as well as parenchymal destruction, including emphysema. Most people with COPD have both emphysema and chronic bronchitis, but the severity of each type can be different from person to person. The COPD marketed and...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.